PON1 and cardiovascular disorder: Individuals that maintained CD4+ T-cells within normal ranges and undetectable HIV-1 RNA levels, as a result of HAART, showed a restoration of the immune system function and of PON1 activity, which could lead and conduce to a lower risk for cardiovascular disease.